PTEN and SHIP2 phosphoinositide phosphatases as negative regulators of insulin signalling

Archives of Physiology and Biochemistry

Volumn 112, Issue 2, 2006, Pages 89-104

  Vinciguerra, Manlio ^a   Foti, Michelangelo ^a,b  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b Centre Médical Universitaire   (Switzerland)

Author keywords

Diabetes; Insulin resistance; Insulin signalling; Phosphoinositide phosphatases; PTEN; SHIP2

Indexed keywords

INSULIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; PROTEIN SUBUNIT; PROTEIN TYROSINE PHOSPHATASE; SH2 CONTAINING INOSITOL 5' PHOSPHATASE; UNCLASSIFIED DRUG;

CATALYSIS; CELL FUNCTION; CONFERENCE PAPER; DIABETES MELLITUS; DOWN REGULATION; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; FATTY LIVER; GLUCOSE TOLERANCE; GLUCOSE TRANSPORT; HUMAN; INSULIN RESISTANCE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; INSULIN; MODELS, BIOLOGICAL; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION;

EID: 33748657133     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450600711359     Document Type: Conference Paper

References (164)

1. Adams LA, Angulo P. 2005. Recent concepts in non-alcoholic fatty liver diseazse. Diabet Med 22(9):1129-33.
2. Aman MJ, Lamkin TD, Okada H, Kurosaki T, Ravichandran KS. 1998. The inositol phosphatase SHIP inhibits Akt/PKB activation in B cells. J Biol Chem 273(51):33922-8.
3. Avruch, J. 1998. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 182(1-2):31-48.
4. Baumann CA, Brady MJ, Saltiel AR. 2001. Activation of glycogen synthase by insulin in 3T3-L1 adipocytes involves c-Cbl-associating protein (CAP)-dependent and CAP-independent signaling pathways. J Biol Chem 276(9):6065-8.
5. Baumann CA, Ribon V, Kanzaki M, Thurmond DC, Mora S, Shigematsu S, Bickel PE, Pessin JE, Saltiel AR. 2000. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 407(6801):202-7.
6. Beitner-Johnson D, Blakesley VA, Shen-Orr Z, Jimenez M, Stannard B, Wang LM, Pierce J, LeRoith D. 1996. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling. J Biol Chem 271(16):9287-90.
7. Blero D, De Smedt F, Pesesse X, Paternotte N, Moreau C, Payrastre B, Erneux C. 2001. The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Biochem Biophys Res Commun 282(3):839-43.
8. Bollag GE, Roth RA, Beaudoin J, Mochly-Rosen D, Koshland Jr DE. 1986. Protein kinase C directly phosphorylates the insulin receptor in vitro and reduces its protein-tyrosine kinase activity. Proc Natl Acad Sci USA 83(16):5822-4.
9. Bossenmaier B, Mosthaf L, Mischak H, Ullrich A, Haring HU. 1997. Protein kinase C isoforms beta 1 and beta 2 inhibit the tyrosine kinase activity of the insulin receptor. Diabetologia 40(7):863-6.
10. Brady MJ, Saltiel AR. 2001. The role of protein phosphatase-1 in insulin action. Recent Prog Horm Res 56:157-73.
11. Buday L. 1999. Membrane-targeting of signalling molecules by SH2/SH3 domain-containing adaptor proteins. Biochim Biophys Acta 1422(2):187-204.
12. Bugianesi E, McCullough AJ, Marchesini G. 2005. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 42(5):987-1000.
13. Bugianesi E, Zannoni C, Vanni E, Marzocchi R, Marchesini G. 2004. Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liver Dis 36(3):165-73.
14. Butler M, McKay RA, Popoff IJ, Gaarde WA, Witchell D, Murray SF, Dean NM, Bhanot S, Monia BP. 2002. Specific inhibition of PTEN expression reverses hyperglycemia in diabetic mice. Diabetes 51(4):1028-34.
15. Byon JC, Kusari AB, Kusari J. 1998. Protein-tyrosine phosphatase-1B acts as a negative regulator of insulin signal transduction.Mol Cell Biochem 182(1-2):101-8.
16. Cantley LC. 2002. The phosphoinositide 3-kinase pathway. Science 296(5573):1655-7.
17. Chan TO, Rittenhouse SE, Tsichlis PN. 1999. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide- dependent phosphorylation. Annu Rev Biochem 68:965-1014.
18. Chaussade C, Pirola L, Bonnafous S, Blondeau F, Brenz-Verca S, Tronchere H, Portis F, Rusconi S, Payrastre B, Laporte J, Van Obberghen E. 2003. Expression of myotubularin by an adenoviral vector demonstrates its function as a phosphatidy-linositol 3-phosphate [PtdIns(3)P] phosphatase in muscle cell lines: involvement of PtdIns(3)P in insulin-stimulated glucose transport. Mol Endocrinol 17(12):2448-60.
19. Cheng A, Dube N, Gu F, Tremblay ML. 2002. Coordinated action of protein tyrosine phosphatases in insulin signal transduction. Eur J Biochem 269(4):1050-9.
20. Chiang SH, Baumann CA, Kanzaki M, Thurmond DC, Watson RT, Neudauer CL, Macara IG, Pessin JE, Saltiel AR. 2001. Insulin-stimulated GLUT4 translocation requires the CAP-dependent activation of TC10. Nature 410(6831):944-8.
21. Cho SH, Lee CH, Ahn Y, Kim H, Ahn CY, Yang KS, Lee SR. 2004. Redox regulation of PTEN and protein tyrosine phosphatases in H(2)O(2) mediated cell signaling. FEBS Lett 560(1-3):7-13.
22. Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S. 2001. The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 409(6816):92-7.
23. Connor KM, Subbaram S, Regan KJ, Nelson KK, Mazurkiewicz JE, Bartholomew PJ, Aplin AE, Tai YT, Aguirre-Ghiso J, Flores SC, Melendez JA. 2005. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. J Biol Chem 280(17):16916-24.
24. Danielsson A, Ost A, Nystrom FH, Stralfors P. 2005. Attenuation of insulin-stimulated insulin receptor substrate-1 serine 307 phosphorylation in insulin resistance of type 2 diabetes. J Biol Chem 280(41):34389-92.
25. De Fea K, Roth RA. 1997. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase. J Biol Chem 272(50):31400-6.
26. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, et al. 1994. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J 13(3):522-33.
27. Di Cristofano A, Pandolfi PP. 2000. The multiple roles of PTEN in tumor suppression. Cell 100(4):387-90.
28. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP. 1998. PTEN is essential for embryonic development and tumour suppression. Nat Genet 19(4):348-55.
29. Dorrestijn J, van Bussel FJ, Maassen JA, Gomes de Mesquita DS. 1998. Early steps in insulin action. Arch Physiol Biochem 106(4):269-89.
30. Dufresne C, Roy P, Wang Z, Asante-Appiah E, Cromlish W, Boie Y, Forghani F, Desmarais S, Wang Q, Skorey K, Waddleton D, Ramachandran C, Kennedy BP, Xu L, Gordon R, Chan CC, Leblanc Y. 2004. The development of potent non-peptidic PTP-1B inhibitors. Bioorg Med Chem Lett 14(4):1039-42.
31. Dyson JM, O'Malley CJ, Becanovic J, Munday AD, Berndt MC, Coghill ID, Nandurkar HH, Ooms LM, Mitchell CA. 2001. The SH2-containing inositol polyphosphate 5-phosphatase, SHIP-2, binds filamin and regulates submembraneous actin. J Cell Biol 155(6):1065-79.
32. Dyson JM, Kong AM, Wiradjaja F, Astle MV, Gurung R, Mitchell CA. 2005. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2. Int J Biochem Cell Biol 37(11):2260-5.
33. Echwald SM, Bach H, Vestergaard H, Richelsen B, Kristensen K, Drivsholm T, Borch-Johnsen K, Hansen T, Pedersen O. 2002. A P387L variant in protein tyrosine phosphatase-1B (PTP-1B) is associated with type 2 diabetes and impaired serine phosphorylation of PTP-1B in vitro. Diabetes 51(1):1-6.
34. Elchebly M, Payette P, Michaliszyn E, Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J, Chan CC, Ramachandran C, Gresser MJ, Tremblay ML, Kennedy BP. 1999. Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science 283(5407):1544-8.
35. Eldar-Finkelman H, Krebs EG. 1997. Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action. Proc Natl Acad Sci USA 94(18):9660-4.
36. Farrell GC. 2005. Signalling links in the liver: knitting SOCS with fat and inflammation. J Hepatol 43(1):193-6.
37. Foukas LC, Beeton CA, Jensen J, Phillips WA, Shepherd PR. 2004. Regulation of phosphoinositide 3-kinase by its intrinsic serine kinase activity in vivo. Mol Cell Biol 24(3):966-75.
38. Franke TF, Kaplan DR, Cantley LC, Toker A. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidy-linositol-3,4-bisphosphate. Science 275(5300):665-8.
39. Fukui K, Wada T, Kagawa S, Nagira K, Ikubo M, Ishihara H, Kobayashi M, Sasaoka T. 2005. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5′-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 54(7):1958-7.
40. Furlanetto RW, Dey BR, Lopaczynski W, Nissley SP. 1997. 14-3-3 proteins interact with the insulin-like growth factor receptor but not the insulin receptor. Biochem J 327(Pt 3):765-71.
41. Gao Z, Hwang D, Bataille F, Lefevre M, York D, Quon MJ, Ye J. 2002. Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex. J Biol Chem 277(50):48115-21.
42. Gao T, Furnari F, Newton AC. 2005. PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth. Mol Cell 18(1):13-24.
43. Giraud J, Leshan R, Lee YH, White MF. 2004. Nutrient-dependent and insulin-stimulated phosphorylation of insulin receptor substrate-1 on serine 302 correlates with increased insulin signaling. J Biol Chem 279(5):3447-54.
44. Goldfine AB, Simonson DC, Folli F, Patti ME, Kahn CR. 1995. In vivo and in vitro studies of vanadate in human and rodent diabetes mellitus. Mol Cell Biochem 153(1-2):217-31.
45. Goldfine ID. 1987. The insulin receptor: molecular biology and transmembrane signaling. Endocr Rev 8(3):235-55.
46. Goldstein BJ, Ahmad F, Ding W, Li PM, Zhang WR. 1998. Regulation of the insulin signalling pathway by cellular protein-tyrosine phosphatases. Mol Cell Biochem 182(1-2):91-9.
47. Goldstein BJ, Bittner-Kowalczyk A, White MF, Harbeck M. 2000. Tyrosine dephosphorylation and deactivation of insulin receptor substrate-1 by protein-tyrosine phosphatase 1B. Possible facilitation by the formation of a ternary complex with the Grb2 adaptor protein. J Biol Chem 275(6):4283-9.
48. Goldstein BJ, Mahadev K, Wu X. 2005. Redox paradox: insulin action is facilitated by insulin-stimulated reactive oxygen species with multiple potential signaling targets. Diabetes 54(2):311-21.
49. Greene MW, Garofalo RS. 2002. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemistry 41(22):7082-91.
50. Gribble FM. 2005. Metabolism: a higher power for insulin. Nature 434(7036):965-6.
51. Gu J, Tamura M, Yamada KM. 1998. Tumor suppressor PTEN inhibits integrin- and growth factor-mediated mitogen-activated protein (MAP) kinase signaling pathways. J Cell Biol 143(5):1375-83.
52. Gu J, Tamura M, Pankov R, Danen EH, Takino T, Matsumoto K, Yamada KM. 1999. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J Cell Biol 146(2):389-403.
53. Gual P, Le Marchand-Brustel Y, Tanti JF. 2005. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 87(1):99-109.
54. Habib T, Hejna JA, Moses RE, Decker SJ. 1998. Growth factors and insulin stimulate tyrosine phosphorylation of the 51C/SHIP2 protein. J Biol Chem 273(29):18605-9.
55. Halstead JR, Jalink K, Divecha N. 2005. An emerging role for PtdIns(4,5)P2-mediated signalling in human disease. Trends Pharmacol Sci 26(12):654-60.
56. Hirosumi J, Tuncman G, Chang L, Gorgun CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. 2002. A central role for JNKin obesity and insulin resistance. Nature 420(6913):333-6.
57. Holt LJ, Siddle K. 2005. Grb10 and Grb14: enigmatic regulators of insulin action - and more? Biochem J 388(Pt 2):393-406.
58. Hori H, Sasaoka T, Ishihara H, Wada T, Murakami S, Ishiki M, Kobayashi M. 2002. Association of SH2-containing inositol phosphatase 2 with the insulin resistance of diabetic db/db mice. Diabetes 51(8):2387-94.
59. Horie Y, Suzuki A, Kataoka E, Sasaki T, Hamada K, Sasaki J, Mizuno K, Hasegawa G, Kishimoto H, Iizuka M, Naito M, Enomoto K, Watanabe S, Mak TW, Nakano T. 2004. Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas. J Clin Invest 113(12):1774-83.
60. Ishihara H, Sasaoka T, Hori H, Wada T, Hirai H, Haruta T, Langlois WJ, Kobayashi M. 1999. Molecular cloning of rat SH2-containing inositol phosphatase 2 (SHIP2) and its role in the regulation of insulin signaling. Biochem Biophys Res Commun 260(1):265-72.
61. Ishihara H, Sasaoka T, Ishiki M, Wada T, Hori H, Kagawa S, Kobayashi M. 2002. Membrane localization of Src homology 2-containing inositol 50-phosphatase 2 via Shc association is required for the negative regulation of insulin signaling in Rat1 fibroblasts overexpressing insulin receptors. Mol Endocrinol 16(10):2371-81.
62. Jakobsen SN, Hardie DG, Morrice N, Tornqvist HE. 2001. 50-AMP-activated protein kinase phosphorylates IRS-1 on Ser-789 in mouse C2C12 myotubes in response to 5-aminoimidazole-4-carboxamide riboside. J Biol Chem 276(50):46912-6.
63. JeBailey L, Rudich A, Huang X, Di Ciano-Oliveira C, Kapus A, Klip A. 2004. Skeletal muscle cells and adipocytes differ in their reliance on TC10 and Rac for insulin-induced actin remodeling. Mol Endocrinol 18(2):359-72.
64. Johnston AM, Pirola L, Van Obberghen E. 2003. Molecular mechanisms of insulin receptor substrate protein-mediated modulation of insulin signalling. FEBS Lett 546(1):32-6.
65. Khan AH, Pessin JE. 2002. Insulin regulation of glucose uptake: a complex interplay of intracellular signalling pathways. Diabetologia 45(11):1475-83.
66. Kimber WA, Deak M, Prescott AR, Alessi DR. 2003. Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1. Biochem J 376(Pt 2):525-35.
67. King H, Aubert RE, Herman WH. 1998. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 21(9):1414-31.
68. Klippel A, Kavanaugh WM, Pot D, Williams LT. 1997. A specific product of phosphatidylinositol 3-kinase directly activates the protein kinase Akt through its pleckstrin homology domain. Mol Cell Biol 17(1):338-44.
69. Komazawa N, Matsuda M, Kondoh G, Mizunoya W, Iwaki M, Takagi T, Sumikawa Y, Inoue K, Suzuki A, Mak TW, Nakano T, Fushiki T, Takeda J, Shimomura I. 2004. Enhanced insulin sensitivity, energy expenditure and thermogenesis in adiposespecific Pten suppression in mice. Nat Med 10(11):1208-15.
70. Kotani K, Wilden P, Pillay TS. 1998. SH2-Balpha is an insulinreceptor adapter protein and substrate that interacts with the activation loop of the insulin-receptor kinase. Biochem J 335(Pt 1):103-9.
71. Krebs DL, Hilton DJ. 2000. SOCS: physiological suppressors of cytokine signaling. J Cell Sci 113(Pt 16):2813-9.
72. Krebs DL, Hilton DJ. 2001. SOCS proteins: negative regulators of cytokine signaling. Stem Cells 19(5):378-87.
73. Kurlawalla-Martinez C, Stiles B, Wang Y, Devaskar SU, Kahn BB, Wu H. 2005. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue. Mol Cell Biol 25(6):2498-510.
74. Kushner JA, Simpson L, Wartschow LM, Guo S, Rankin MM, Parsons R, White MF. 2005. Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis. J Biol Chem 280(47):39388-93.
75. Laviola L, Giorgino F, Chow JC, Baquero JA, Hansen H, Ooi J, Zhu J,RiedelH, SmithRJ. 1997. The adapter proteinGrb10 associates preferentially with the insulin receptor as compared with the IGF-I receptor in mouse fibroblasts. J Clin Invest 99(5):830-7.
76. Lee YH, Giraud J, Davis RJ, White MF. 2003. c-Jun N-terminal kinase (JNK) mediates feedback inhibition of the insulin signaling cascade. J Biol Chem 278(5):2896-902.
77. Leslie NR, Bennett D, Lindsay YE, Stewart H, Gray A, Downes CP. 2003. Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J 22(20):5501-10.
78. Leslie NR, Downes CP. 2004. PTEN function: how normal cells control it and tumour cells lose it. Biochem J 382(Pt 1):1-11.
79. Li J, DeFea K, Roth RA. 1999. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J Biol Chem 274(14):9351-6.
80. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275(5308):1943-7.
81. Li L, Gronning LM, Anderson PO, Li S, Edvardsen K, Johnston J, Kioussis D, Shepherd PR, Wang P. 2004. Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism. J Biol Chem 279(33):34107-14.
82. Liu YF, Paz K, Herschkovitz A, Alt A, Tennenbaum T, Sampson SR, Ohba M, Kuroki T, LeRoith D, Zick Y. 2001. Insulin stimulates PKCzeta-mediated phosphorylation of insulin receptor substrate-1 (IRS-1). A self-attenuated mechanism to negatively regulate the function of IRS proteins. J Biol Chem 276(17):14459-65.
83. Liu J, DeYoung SM, Hwang JB, O'Leary EE, Saltiel AR. 2003. The roles of Cbl-b and c-Cbl in insulin-stimulated glucose transport. J Biol Chem 278(38):36754-62.
84. Liu JL, Sheng X, Hortobagyi ZK, Mao Z, Gallick GE, Yung WK. 2005. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Mol Cell Biol 25(14):6211-24.
85. Lo YT, Tsao CJ, Liu IM, Liou SS, Cheng JT. 2004. Increase of PTEN gene expression in insulin resistance. Horm Metab Res 36(10):662-6.
86. Lock P, Casagranda F, Dunn AR. 1999. Independent SH2-binding sites mediate interaction of Dok-related protein with RasGTPase-activating protein and Nck. J Biol Chem 274(32):22775-84.
87. Lopaczynski W. 1999. Differential regulation of signaling pathways for insulin and insulin-like growth factor I. Acta Biochim Pol 46(1):51-60.
88. Maegawa H, Hasegawa M, Sugai S, Obata T, Ugi S, Morino K, Egawa K, Fujita T, Sakamoto T, Nishio Y, Kojima H, Haneda M, Yasuda H, Kikkawa R, Kashiwagi A. 1999. Expression of a dominant negative SHP-2 in transgenic mice induces insulin resistance. J Biol Chem 274(42):30236-43.
89. Mander A, Hodgkinson CP, Sale GJ. 2005. Knock-down of LAR protein tyrosine phosphatase induces insulin resistance. FEBS Lett 579(14):3024-8.
90. Manning BD. 2004. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. J Cell Biol 167(3):399-403.
91. Marchesini G, Brizi M, Morselli-Labate AM, Bianchi G, Bugianesi E, McCullough AJ, Forlani G, Melchionda N. 1999. Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med 107(5):450-5.
92. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M. 2003. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 37(4):917-23.
93. McGuire MC, Fields RM, Nyomba BL, Raz I, Bogardus C, Tonks NK, Sommercorn J. 1991. Abnormal regulation of protein tyrosine phosphatase activities in skeletal muscle of insulin-resistant humans. Diabetes 40(7):939-42.
94. Millward TA, Zolnierowicz S, Hemmings BA. 1999. Regulation of protein kinase cascades by protein phosphatase 2A. Trends Biochem Sci 24(5):186-91.
95. Mitra P, Zheng X, Czech MP. 2004. RNAi-based analysis of CAP, Cbl, and CrkII function in the regulation of GLUT4 by insulin. J Biol Chem 279(36):37431-5.
96. Moeschel K, Beck A, Weigert C, Lammers R, Kalbacher H, Voelter W, Schleicher ED, Haring HU, Lehmann R. 2004. Protein kinase C-zeta-induced phosphorylation of Ser318 in insulin receptor substrate-1 (IRS-1) attenuates the interaction with the insulin receptor and the tyrosine phosphorylation of IRS-1. J Biol Chem 279(24):25157-63.
97. Mooney RA, Senn J, Cameron S, Inamdar N, Boivin LM, Shang Y, Furlanetto RW. 2001. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance. J Biol Chem 276(28):25889-93.
98. Mora A, Komander D, van Aalten DM, Alessi DR. 2004. PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 15(2):161-70.
99. Mothe I, Van Obberghen E. 1996. Phosphorylation of insulin receptor substrate-1 on multiple serine residues, 612, 632, 662, and 731, modulates insulin action. J Biol Chem 271(19):11222-7.
100. Murakami S, Sasaoka T, Wada T, Fukui K, Nagira K, Ishihara H, Usui I, Kobayashi M. 2004. Impact of Src homology 2-containing inositol 50-phosphatase 2 on the regulation of insulin signaling leading to protein synthesis in 3T3-L1 adipocytes cultured with excess amino acids. Endocrinology 145(7):3215-23.
101. Najjar SM, Philippe N, Taylor SI, Accili D. 1993. Molecular cloning of pp120/ECTO-ATPase, an endogenous substrate of the insulin receptor kinase. Adv Exp Med Biol 343:169-74.
102. Nakashima N, Sharma PM, Imamura T, Bookstein R, Olefsky JM. 2000. The tumor suppressor PTEN negatively regulates insulin signaling in 3T3-L1 adipocytes. J Biol Chem 275(17):12889-95.
103. Neid M, Datta K, Stephan S, Khanna I, Pal S, Shaw L, White M, Mukhopadhyay D. 2004. Role of insulin receptor substrates and protein kinase C-zeta in vascular permeability factor/vascular endothelial growth factor expression in pancreatic cancer cells. J Biol Chem 279(6):3941-8.
104. Noguchi T, Matozaki T, Inagaki K, Tsuda M, Fukunaga K, Kitamura Y, Kitamura T, Shii K, Yamanashi Y, Kasuga M. 1999. Tyrosine phosphorylation of p62(Dok) induced by cell adhesion and insulin: possible role in cell migration. EMBO J 18(7):1748-60.
105. Ono H, Katagiri H, Funaki M, Anai M, Inukai K, Fukushima Y, Sakoda H, Ogihara T, Onishi Y, Fujishiro M, Kikuchi M, Oka Y, Asano T. 2001. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Mol Endocrinol 15(8):1411-22.
106. Palmer ND, Bento JL, Mychaleckyj JC, Langefeld CD, Campbell JK, Norris JM, Haffner SM, Bergman RN, Bowden DW. 2004. Association of protein tyrosine phosphatase 1B gene polymorphisms with measures of glucose homeostasis in Hispanic Americans: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 53(11):3013-9.
107. Patel L, Pass I, Coxon P, Downes CP, Smith SA, Macphee CH. 2001. Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol 11(10):764-8.
108. Pawson T, Scott JD. 1997. Signaling through scaffold, anchoring, and adaptor proteins. Science 278(5346):2075-80.
109. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y. 1997. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their binding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J Biol Chem 272(47):29911-8.
110. Paz K, Liu YF, Shorer H, Hemi R, LeRoith D, Quan M, Kanety H, Seger R, Zick Y. 1999. Phosphorylation of insulin receptor substrate-1 (IRS-1) by protein kinase B positively regulates IRS-1 function. J Biol Chem 274(40):28816-22.
111. Pederson TM, Kramer DL, Rondinone CM. 2001. Serine/threonine phosphorylation of IRS-1 triggers its degradation: possible regulation by tyrosine phosphorylation. Diabetes 50(1):24-31.
112. Pendaries C, Tronchere H, Racaud-Sultan C, Gaits-Iacovoni F, Coronas S, Manenti S, Gratacap MP, Plantavid M, Payrastre B. 2005. Emerging roles of phosphatidylinositol monophosphates in cellular signaling and trafficking. Adv Enzyme Regul 45:201-14.
113. Pessin JE, Saltiel AR. 2000. Signaling pathways in insulin action: molecular targets of insulin resistance. J Clin Invest 106(2):165-9.
114. Philp AJ, Campbell IG, Leet C, Vincan E, Rockman SP, Whitehead RH, Thomas RJ, Phillips WA. 2001. The phosphatidylinositol 30-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res 61(20):7426-9.
115. Powell EE, Jonsson JR, Clouston AD. 2005. Steatosis: co-factor in other liver diseases. Hepatology 42(1):5-13.
116. Ravichandran LV, Esposito DL, Chen J, Quon MJ. 2001. Protein kinase C-zeta phosphorylates insulin receptor substrate-1 and impairs its ability to activate phosphatidylinositol 3-kinase in response to insulin. J Biol Chem 276(5):3543-9.
117. Rui L, Yuan M, Frantz D, Shoelson S, White MF. 2002. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 277(44):42394-8.
118. Salmeen A, Andersen JN, Myers MP, Tonks NK, Barford D. 2000. Molecular basis for the dephosphorylation of the activation segment of the insulin receptor by protein tyrosine phosphatase 1B. Mol Cell 6(6):1401-12.
119. Saltiel AR, Kahn CR. 2001. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 414(6865):799-806.
120. Sansal I, Sellers WR. 2004. The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol 22(14):2954-63.
121. Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. 2001. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120(5):1183-92.
122. Sasaoka T, Hori H, Wada T, Ishiki M, Haruta T, Ishihara H, Kobayashi M. 2001. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 44(10):1258-67.
123. Sasaoka T, Wada T, Fukui K, Murakami S, Ishihara H, Suzuki R, Tobe K, Kadowaki T, Kobayashi M. 2004. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes. J Biol Chem 279(15):14835-43.
124. Sasaoka T, Fukui K, Wada T, Murakami S, Kawahara J, Ishihara H, Funaki M, Asano T, Kobayashi M. 2005. Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes. Diabetologia 48(2):336-44.
125. Schmid AC, Woscholski R. 2004. Phosphatases as small-molecule targets: inhibiting the endogenous inhibitors of kinases. Biochem Soc Trans 32(Pt 2):348-9.
126. Sesti G, Federici M, Hribal ML, Lauro D, Sbraccia P, Lauro R. 2001. Defects of the insulin receptor substrate (IRS) system in human metabolic disorders. FASEB J 15(12):2099-111.
127. Sharma PM, Son HS, Ugi S, Ricketts W, Olefsky JM. 2005. Mechanism of SHIP-mediated inhibition of insulin- and platelet-derived growth factor-stimulated mitogen-activated protein kinase activity in 3T3-L1 adipocytes. Mol Endocrinol 19(2):421-30.
128. Shepherd PR. 2005. Mechanisms regulating phosphoinositide 3-kinase signalling in insulin-sensitive tissues. Acta Physiol Scand 183(1):3-12.
129. Siddle K, Urso B, Niesler CA, Cope DL, Molina L, Surinya KH, Soos MA. 2001. Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochem Soc Trans 29(Pt 4):513-25.
130. Sleeman MW, Wortley KE, Lai KM, Gowen LC, Kintner J, Kline WO, Garcia K, Stitt TN, Yancopoulos GD, Wiegand SJ, Glass DJ. 2005. Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat Med 11(2):199-205.
131. Sontag E. 2001. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal 13(1):7-16.
132. Standaert ML, Bandyopadhyay G, Sajan MP, Cong L, Quon MJ, Farese RV. 1999. Okadaic acid activates atypical protein kinase C (zeta/lambda) in rat and 3T3/L1 adipocytes. An apparent requirement for activation of Glut4 translocation and glucose transport. J Biol Chem 274(20):14074-8.
133. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identi-fication of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15(4):356-62.
134. Stiles B, Wang Y, Stahl A, Bassilian S, Lee WP, Kim YJ, Sherwin R, Devaskar S, Lesche R, Magnuson MA, Wu H. 2004. Liver-specific deletion of negative regulator PTEN results in fatty liver and insulin hypersensitivity [corrected]. Proc Natl Acad Sci USA 101(7):2082-7.
135. Strack V, Hennige AM, Krutzfeldt J, Bossenmaier B, Klein HH, Kellerer M, Lammers R, Haring HU. 2000. Serine residues 994 and 1023/25 are important for insulin receptor kinase inhibition by protein kinase C isoforms beta2 and theta. Diabetologia 43(4):443-9.
136. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW. 1998. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8(21):1169-78.
137. Takayama S, Kahn CR, Kubo K, Foley JE. 1988. Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. J Clin Endocrinol Metab 66(5):992-9.
138. Tang X, Powelka AM, Soriano NA, Czech MP, Guilherme A. 2005. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. J Biol Chem 280(23):22523-9.
139. Teresi RE, Shaiu CW, Chen CS, Chatterjee VK, Waite KA, Eng C. 2006. Increased PTEN expression due to transcriptional activation of PPARgamma by Lovastatin and Rosiglitazone. Int J Cancer 118(10):2390-8.
140. Thirone AC, Carvalheira JB, Hirata AE, Velloso LA, Saad MJ. 2004. Regulation of Cbl-associated protein/Cbl pathway in muscle and adipose tissues of two animal models of insulin resistance. Endocrinology 145(1):281-93.
141. Tirosh A, Potashnik R, Bashan N, Rudich A. 1999. Oxidative stress disrupts insulin-induced cellular redistribution of insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. A putative cellular mechanism for impaired protein kinase B activation and GLUT4 translocation. J Biol Chem 274(15):10595-602.
142. Tonks NK, Diltz CD, Fischer EH. 1991. Purification of proteintyrosine phosphatases from human placenta. Methods Enzymol 201:427-42.
143. Ueki K, Kadowaki T, Kahn CR. 2005. Role of suppressors of cytokine signaling SOCS-1 and SOCS-3 in hepatic steatosis and the metabolic syndrome. Hepatol Res 33(2):185-92.
144. Ugi S, Imamura T, Ricketts W, Olefsky JM. 2002. Protein phosphatase 2A forms a molecular complex with Shc and regulates Shc tyrosine phosphorylation and downstream mitogenic signaling. Mol Cell Biol 22(7):2375-87.
145. Ugi S, Imamura T, Maegawa H, Egawa K, Yoshizaki T, Shi K, Obata T, Ebina Y, Kashiwagi A, Olefsky JM. 2004. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes. Mol Cell Biol 24(19):8778-89.
146. Um SH, Frigerio F,Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas G. 2004. Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 431(7005):200-5.
147. Unger RH. 2002. Lipotoxic diseases. Annu Rev Med 53:319-36.
148. Vandenbroere I, Paternotte N, Dumont JE, Erneux C, Pirson I. 2003. The c-Cbl-associated protein and c-Cbl are two new partners of the SH2-containing inositol polyphosphate 5-phosphatase SHIP2. Biochem Biophys Res Commun 300(2):494-500.
149. Vanhaesebroeck B, Alessi DR. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346 Pt 3:561-76.
150. Virkamaki A, Ueki K, Kahn CR. 1999. Protein - protein interaction in insulin signaling and the molecular mechanisms of insulin resistance. J Clin Invest 103(7):931-43.
151. Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M. 2001. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 50-phosphatase catalytic activity. Mol Cell Biol 21(5):1633-46.
152. Weng LP, Smith WM, Brown JL, Eng C. 2001. PTEN inhibits insulin-stimulated MEK/MAPK activation and cell growth by blocking IRS-1 phosphorylation and IRS-1/Grb-2/Sos complex formation in a breast cancer model. Hum Mol Genet 10(6):605-16.
153. Weng LP, Brown JL, Baker KM, Ostrowski MC, Eng C. 2002. PTEN blocks insulin-mediated ETS-2 phosphorylation through MAP kinase, independently of the phosphoinositide 3-kinase pathway. Hum Mol Genet 11(15):1687-96.
154. White MF. 1998. The IRS-signalling system: a network of docking proteins that mediate insulin action. Mol Cell Biochem 182(1-2):3-11.
155. White MF, Kahn CR. 1994. The insulin signaling system. J Biol Chem 269(1):1-4.
156. Wijesekara N, Konrad D, Eweida M, Jefferies C, Liadis N, Giacca A, Crackower M, Suzuki A, Mak TW, Kahn CR, Klip A, WooM. 2005. Muscle-specific PTEN deletion protects against insulin resistance and diabetes. Mol Cell Biol 25(3):1135-45.
157. Wu X, Senechal K, Neshat MS, Whang YE, Sawyers CL. 1998. The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci USA 95(26):15587-91.
158. Yenush L, White MF. 1997. The IRS-signalling system during insulin and cytokine action. Bioessays 19(6):491-500.
159. Yenush L, Makati KJ, Smith-Hall J, Ishibashi O, Myers Jr MG, White MF. 1996. The pleckstrin homology domain is the principal link between the insulin receptor and IRS-1. J Biol Chem 271(39):24300-6.
160. Yuan M, Konstantopoulos N, Lee J, Hansen L, Li ZW, Karin M, Shoelson SE. 2001. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta. Science 293(5535):1673-7.
161. Zabolotny JM, Kim YB, Peroni OD, Kim JK, Pani MA, Boss O, Klaman LD, Kamatkar S, Shulman GI, Kahn BB, Neel BG. 2001. Overexpression of the LAR (leukocyte antigen-related) protein-tyrosine phosphatase in muscle causes insulin resistance. Proc Natl Acad Sci USA 98(9):5187-92.
162. Zabolotny JM, Haj FG, Kim YB, Kim HJ, Shulman GI, Kim JK, Neel BG, Kahn BB. 2004. Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action. J Biol Chem 279(23):24844-51.
163. Zick Y. 2001. Insulin resistance: a phosphorylation-based uncoupling of insulin signaling. Trends Cell Biol 11(11):437-41.
164. Zimmet P, Alberti KG, Shaw J. 2001. Global and societal implications of the diabetes epidemic. Nature 414(6865):782-7.